Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 5 Results

Title
Intervention Indication Therapeutic Area Year Actions
Eryaspase in addition to chemotherapy for treating advanced or metastatic pancreatic cancer – second-line Eryaspase (Graspa; ERY001) , FOLFOX4 , Gemcitabine (Gemzar; gemcitabine hydrochloride) Pancreatic cancer Gastrointestinal Cancer 2020 View  |  Download
Nab-paclitaxel in Combination with Gemcitabine for Resected Pancreatic Ductal Adenocarcinoma - Adjuvant Therapy Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) Pancreatic cancer Gastrointestinal Cancer 2017 View  |  Download
Olaparib for Metastatic Pancreatic Cancer with gBRCA Mutation Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Pancreatic cancer Gastrointestinal Cancer 2018 View  |  Download
PEGPH20 in addition to Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Ductal Adenocarcinoma Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , Pegvorhyaluronidase alfa (PEGPH20) Pancreatic cancer Gastrointestinal Cancer 2018 View  |  Download
siG12D‐LODER in addition to standard chemotherapy for locally advanced pancreatic cancer Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , siG12D-LODER Pancreatic cancer Gastrointestinal Cancer 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications